Sandy J. Wilson

发表

The first potent and selective non-imidazole human histamine H4 receptor antagonists.

J. A. Jablonowski, Cheryl A. Grice, W. Chai, 2003, Journal of medicinal chemistry.

α-Substituted N-(Sulfonamido)alkyl-β-aminotetralins: Potent and Selective Neuropeptide Y Y5 Receptor Antagonists

Allen B. Reitz, Sandy J. Wilson, T. Lovenberg, 2000 .

Preclinical Characterization of the FAAH Inhibitor JNJ-42165279.

Sandy J. Wilson, M. Karbarz, S. Chaplan, 2015, ACS medicinal chemistry letters.

Novel imidazole-based histamine H3 antagonists.

J. A. Jablonowski, C. Dvorak, Kiev S. Ly, 2009, Bioorganic & medicinal chemistry letters.

Heterocyclic replacement of the central phenyl core of diamine-based histamine H3 receptor antagonists.

P. Bonaventure, Sandy J. Wilson, T. Lovenberg, 2009, European journal of medicinal chemistry.

Novel human histamine H(3) receptor antagonists.

Sandy J. Wilson, T. Lovenberg, N. Carruthers, 2002, Bioorganic & medicinal chemistry letters.

A new class of diamine-based human histamine H3 receptor antagonists: 4-(aminoalkoxy)benzylamines.

C. Dvorak, Sandy J. Wilson, T. Lovenberg, 2003, Journal of medicinal chemistry.

Non-imidazole heterocyclic histamine H3 receptor antagonists.

W. Chai, Annette K. Kwok, Sandy J. Wilson, 2003, Bioorganic & medicinal chemistry letters.

Acute wake‐promoting actions of JNJ‐5207852, a novel, diamine‐based H3 antagonist

Sandy J. Wilson, T. Lovenberg, N. Carruthers, 2004 .

4-phenoxypiperidines: potent, conformationally restricted, non-imidazole histamine H3 antagonists.

Craig W Berridge, C. Dvorak, Sandy J. Wilson, 2005, Journal of medicinal chemistry.

Heteroaryl urea inhibitors of fatty acid amide hydrolase: structure-mutagenicity relationships for arylamine metabolites.

Mark Seierstad, Sandy J. Wilson, John M. Keith, 2012, Bioorganic & medicinal chemistry letters.

The SAR of brain penetration for a series of heteroaryl urea FAAH inhibitors.

Sandy J. Wilson, M. Karbarz, S. Chaplan, 2016, Bioorganic & medicinal chemistry letters.

Cloning and functional expression of the human histamine H3 receptor.

M. Jackson, B. Roland, M. Erlander, 1999, Molecular pharmacology.

N-Acylated α-(3-pyridylmethyl)-β-aminotetralin antagonists of the human neuropeptide Y Y5 receptor

Sandy J. Wilson, T. Lovenberg, D. Nepomuceno, 2000 .

Aminopyrazoles with High Affinity for the Human Neuropeptide Y5 Receptor.

Sandy J. Wilson, T. Lovenberg, A. Reitz, 2001 .

Pyrazolecarboxamide Human Neuropeptide Y5 Receptor Ligands with in vivo Antifeedant Activity.

Sandy J. Wilson, T. Lovenberg, A. Reitz, 2001 .

Novel tetrahydroisoquinolines are histamine H3 antagonists and serotonin reuptake inhibitors.

P. Bonaventure, J. A. Jablonowski, Kiev S. Ly, 2007, Bioorganic & medicinal chemistry letters.

Novel naphthyridines are histamine H3 antagonists and serotonin reuptake transporter inhibitors.

Kiev S. Ly, Sandy J. Wilson, T. Lovenberg, 2007, Bioorganic & medicinal chemistry letters.

Aryl Piperazinyl Ureas as Inhibitors of Fatty Acid Amide Hydrolase (FAAH) in Rat, Dog, and Primate.

Sandy J. Wilson, M. Karbarz, S. Chaplan, 2012, ACS medicinal chemistry letters.

Biochemical and Biological Properties of 4-(3-phenyl-[1,2,4] thiadiazol-5-yl)-piperazine-1-carboxylic acid phenylamide, a Mechanism-Based Inhibitor of Fatty Acid Amide Hydrolase

Sandy J. Wilson, Jiejun Wu, M. Karbarz, 2009, Anesthesia and analgesia.

Thiadiazolopiperazinyl ureas as inhibitors of fatty acid amide hydrolase.

Sandy J. Wilson, Jiejun Wu, K. Pattabiraman, 2008, Bioorganic & medicinal chemistry letters.

Inhibition of fatty acid amide hydrolase produces analgesia by multiple mechanisms

Sandy J. Wilson, S. Sutton, S. Chaplan, 2006, British journal of pharmacology.

Inhibition of fatty acid amide hydrolase produces analgesia by multiple mechanisms

Sandy J. Wilson, S. Sutton, S. Chaplan, 2006 .

Dual serotonin transporter/histamine H3 ligands: Optimization of the H3 pharmacophore.

J. A. Jablonowski, Kiev S. Ly, Sandy J. Wilson, 2007, Bioorganic & medicinal chemistry letters.

1-Aryl-2-((6-aryl)pyrimidin-4-yl)amino)ethanols as competitive inhibitors of fatty acid amide hydrolase.

Sandy J. Wilson, M. Karbarz, S. Chaplan, 2014, Bioorganic & medicinal chemistry letters.

Pharmacological characterization of JNJ-28583867, a histamine H(3) receptor antagonist and serotonin reuptake inhibitor.

P. Bonaventure, Sandy J. Wilson, T. Lovenberg, 2007, European journal of pharmacology.

Decreased intracellular calcium mediates the histamine H3-receptor-induced attenuation of norepinephrine exocytosis from cardiac sympathetic nerve endings

Sandy J. Wilson, T. Lovenberg, R. Silver, 2001, Proceedings of the National Academy of Sciences of the United States of America.

Pyrrolidino-tetrahydroisoquinolines bearing pendant heterocycles as potent dual H3 antagonist and serotonin transporter inhibitors.

Sandy J. Wilson, T. Lovenberg, N. Carruthers, 2007, Bioorganic & medicinal chemistry letters.

Pyrrolidino-tetrahydroisoquinolines as potent dual H3 antagonist and serotonin transporter inhibitors.

Sandy J. Wilson, T. Lovenberg, N. Carruthers, 2007, Bioorganic & medicinal chemistry letters.

Heterocyclic replacement of the central phenyl core of diamine-based histamine H3 receptor antagonists.

P. Bonaventure, Sandy J. Wilson, T. Lovenberg, 2009, European journal of medicinal chemistry.

Pyrrolidino-tetrahydroisoquinolines as potent dual H3 antagonist and serotonin transporter inhibitors.

Sandy J. Wilson, T. Lovenberg, N. Carruthers, 2007, Bioorganic & medicinal chemistry letters.

Synthesis and biological activity of piperazine and diazepane amides that are histamine H3 antagonists and serotonin reuptake inhibitors.

P. Bonaventure, Kiev S. Ly, Sandy J. Wilson, 2008, Bioorganic & medicinal chemistry letters.

Preparation and biological evaluation of indole, benzimidazole, and thienopyrrole piperazine carboxamides: potent human histamine h(4) antagonists.

J. A. Jablonowski, Cheryl A. Grice, W. Chai, 2005, Journal of medicinal chemistry.

Dual serotonin transporter inhibitor/histamine H3 antagonists: development of rigidified H3 pharmacophores.

Sandy J. Wilson, T. Lovenberg, N. Carruthers, 2007, Bioorganic & medicinal chemistry letters.

Novel glycine transporter type-2 reuptake inhibitors. Part 1: alpha-amino acid derivatives.

Sandy J. Wilson, T. Lovenberg, A. Santillán, 2004, Bioorganic & medicinal chemistry.

Novel glycine transporter type-2 reuptake inhibitors. Part 2: beta- and gamma-amino acid derivatives.

Sandy J. Wilson, T. Lovenberg, A. Santillán, 2004, Bioorganic & medicinal chemistry.

A simple stopped assay for fatty acid amide hydrolase avoiding the use of a chloroform extraction phase.

Sandy J. Wilson, C. Fowler, A. Barbier, 2004, Journal of biochemical and biophysical methods.